Anuh Pharma Limited (BOM:506260)

Anuh Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	21.54	195.57	72.02	19.27	37.96	21.98
Short-Term Investments	109.42	15.02	12.37	8.1	-	49.45
Trading Asset Securities	-	523.56	538.17	503.4	214.69	60.7
Cash & Short-Term Investments	130.96	734.15	622.56	530.77	252.65	132.13
Cash Growth	-74.78%	17.93%	17.29%	110.08%	91.21%	-80.48%
Accounts Receivable	2,351	2,159	1,899	1,712	1,357	1,069
Other Receivables	23.43	97.33	61.96	39.14	5.25	163.64
Receivables	2,381	2,261	1,968	1,756	1,370	1,242
Inventory	1,182	744.81	754	726.36	799.23	814.26
Prepaid Expenses	-	17.72	5.88	5.72	4.79	4.4
Restricted Cash	-	-	-	30.5	-	-
Other Current Assets	94.41	3.54	35.29	26.61	159.98	184.97
Total Current Assets	3,789	3,762	3,385	3,076	2,587	2,377
Property, Plant & Equipment	616.44	583.65	492.42	526.76	613.41	711.83
Long-Term Investments	597.53	619.55	517.14	396.84	212.13	203.71
Other Intangible Assets	0.78	1.21	1.58	1.31	1.83	2.4
Long-Term Deferred Tax Assets	24.03	20.8	4.22	7.68	-	-
Other Long-Term Assets	58.45	77.76	53.99	41.09	57.51	31.16
Total Assets	5,087	5,066	4,457	4,050	3,472	3,326
Accounts Payable	1,650	1,568	1,405	1,528	1,216	1,200
Accrued Expenses	1.67	7.08	6.16	4.74	3.34	3.39
Short-Term Debt	-	104.98	20.13	-	31.11	135.98
Current Portion of Leases	2.27	3.3	2.91	0.67	2.06	0.78
Current Income Taxes Payable	-	5.48	-	-	-	-
Other Current Liabilities	143.95	95.85	92.72	80.29	56.81	54.39
Total Current Liabilities	1,798	1,785	1,527	1,613	1,309	1,395
Long-Term Leases	-	0.58	3.88	8.39	9.07	-
Pension & Post-Retirement Benefits	-	12.92	11.05	9.91	9.72	9.6
Long-Term Deferred Tax Liabilities	-	-	-	-	0.48	10.14
Other Long-Term Liabilities	19.8	7.39	2.75	5.93	5.69	5.53
Total Liabilities	1,817	1,806	1,545	1,638	1,334	1,420
Common Stock	501.12	250.56	250.56	250.56	250.56	250.56
Retained Earnings	-	3,009	2,660	2,160	1,886	1,655
Comprehensive Income & Other	2,768	1.14	1.31	1.69	1.3	0.46
Shareholders' Equity	3,269	3,260	2,912	2,412	2,138	1,906
Total Liabilities & Equity	5,087	5,066	4,457	4,050	3,472	3,326
Total Debt	2.27	108.86	26.93	9.07	42.24	136.75
Net Cash (Debt)	128.69	625.29	595.63	521.7	210.41	-4.63
Net Cash Growth	-65.97%	4.98%	14.17%	147.94%	-	-
Net Cash Per Share	1.28	6.24	5.94	5.21	2.10	-0.05
Filing Date Shares Outstanding	100.16	100.22	100.22	100.22	100.22	100.22
Total Common Shares Outstanding	100.16	100.22	100.22	100.22	100.22	100.22
Working Capital	1,991	1,977	1,858	1,463	1,278	982.61
Book Value Per Share	32.64	32.53	29.06	24.07	21.33	19.02
Tangible Book Value	3,268	3,259	2,911	2,411	2,136	1,904
Tangible Book Value Per Share	32.63	32.52	29.04	24.06	21.31	19.00
Land	-	15.59	15.59	113.07	113.07	113.07
Buildings	-	146.73	146.73	146.73	146.73	146.12
Machinery	-	941.3	767.32	723.6	713.5	709.4
Construction In Progress	-	2.71	4.54	-	1	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.